Literature DB >> 24139856

Racial and ethnic differences in epilepsy classification among probands in the Epilepsy Phenome/Genome Project (EPGP).

Daniel Friedman1, Robyn Fahlstrom.   

Abstract

Little is known about the ethnic and racial differences in the prevalence of generalized and focal epilepsy among patients with non-acquired epilepsies. In this study, we examined epilepsy classification and race/ethnicity in 813 probands from sibling or parent-child pairs with epilepsy enrolled in the Epilepsy Genome/Phenome Project (EPGP). Subjects were classified as generalized epilepsy (GE), non-acquired focal epilepsy (NAFE), mixed epilepsy syndrome (both generalized and focal), and unclassifiable, based on consensus review of semiology and available clinical, electrophysiology, and neuroimaging data. In this cohort, 628 (77.2%) subjects identified exclusively as Caucasian/white and 65 (8.0%) subjects reported African ancestry, including subjects of mixed-race. Of the Caucasian/white subjects, 357 (56.8%) had GE, 207 (33.0%) had NAFE, 32 (5.1%) had a mixed syndrome, and 32 (5.1%) were unclassifiable. Among subjects of African ancestry, 28 (43.1%) had GE, 27 (41.5%) had NAFE, 2 (3.1%) had a mixed syndrome, and 8 (12.3%) were unclassifiable. There was a higher proportion of subjects with GE compared to other syndromes among Caucasians/whites compared to subjects with African ancestry (OR 1.74, 95% CI: 1.04-2.92, two-tailed Fisher's exact test, p=0.036). There was no difference in the rate of GE among subjects reporting Hispanic ethnicity (7.6% of total) when adjusted for race (Caucasian/white vs non-Caucasian/white; OR 0.65, 95% CI: 0.40-1.06, p>0.05). The proportion of participants with unclassifiable epilepsy was significantly greater in those of African-American descent. In a group of patients with epilepsy of unknown etiology and an affected first degree relative, GE is more common among Caucasian/white subjects than among those with African ancestry. These findings suggest there may be geographical differences in the distribution of epilepsy susceptibility genes and an effect of genetic background on epilepsy phenotype. However, the results should be interpreted with caution because of the low numbers of African-Americans in this cohort and more limited diagnostic data available for epilepsy classification in these subjects compared to Caucasians/whites.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epilepsy syndromes; Ethnic differences; Genetics

Mesh:

Year:  2013        PMID: 24139856      PMCID: PMC4176610          DOI: 10.1016/j.eplepsyres.2013.09.007

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  10 in total

Review 1.  Interictal EEG and the diagnosis of epilepsy.

Authors:  Jyoti Pillai; Michael R Sperling
Journal:  Epilepsia       Date:  2006       Impact factor: 5.864

2.  The influence of racial and environmental factors on EEG photoparoxysmal responses in Zimbabwe.

Authors:  B Adamolekun; J B Familusi; B Olayinka; L F Levy
Journal:  Acta Neurol Scand       Date:  1998-01       Impact factor: 3.209

3.  Evidence for a shared genetic susceptibility to migraine and epilepsy.

Authors:  Melodie R Winawer; Robert Connors
Journal:  Epilepsia       Date:  2013-01-07       Impact factor: 5.864

4.  Influence of ethnic and geographic factors on the classic photoparoxysmal response in the electroencephalogram of epilepsy patients.

Authors:  A S de Graaf; C J Lombard; D A Claassen
Journal:  Epilepsia       Date:  1995-03       Impact factor: 5.864

5.  Racial differences in factors that influence the willingness to participate in medical research studies.

Authors:  Vickie L Shavers; Charles F Lynch; Leon F Burmeister
Journal:  Ann Epidemiol       Date:  2002-05       Impact factor: 3.797

6.  Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non-pediatric setting.

Authors:  R Mohanraj; M J Brodie
Journal:  Acta Neurol Scand       Date:  2007-03       Impact factor: 3.209

7.  Diagnosing refractory epilepsy: response to sequential treatment schedules.

Authors:  R Mohanraj; M J Brodie
Journal:  Eur J Neurol       Date:  2006-03       Impact factor: 6.089

8.  Sociodemographic disparities in epilepsy care: Results from the Houston/New York City health care use and outcomes study.

Authors:  Charles E Begley; Rituparna Basu; Thomas Reynolds; David R Lairson; Stephanie Dubinsky; Michael Newmark; Forbes Barnwell; Allen Hauser; Dale Hesdorffer; Nora Hernandez; Steven C Karceski; Tina Shih
Journal:  Epilepsia       Date:  2008-11-17       Impact factor: 5.864

9.  Characterizing the admixed African ancestry of African Americans.

Authors:  Fouad Zakharia; Analabha Basu; Devin Absher; Themistocles L Assimes; Alan S Go; Mark A Hlatky; Carlos Iribarren; Joshua W Knowles; Jun Li; Balasubramanian Narasimhan; Steven Sidney; Audrey Southwick; Richard M Myers; Thomas Quertermous; Neil Risch; Hua Tang
Journal:  Genome Biol       Date:  2009-12-22       Impact factor: 13.583

10.  The Epilepsy Phenome/Genome Project (EPGP) informatics platform.

Authors:  Gerry Nesbitt; Kevin McKenna; Vickie Mays; Alan Carpenter; Kevin Miller; Michael Williams
Journal:  Int J Med Inform       Date:  2012-05-10       Impact factor: 4.046

  10 in total
  3 in total

1.  Depressive Symptom Severity in Individuals With Epilepsy and Recent Health Complications.

Authors:  Neha Kumar; Rigzin Lhatoo; Hongyan Liu; Kari Colon-Zimmermann; Curtis Tatsuoka; Peijun Chen; Mustafa Kahriman; Martha Sajatovic
Journal:  J Nerv Ment Dis       Date:  2019-04       Impact factor: 2.254

2.  Phenotypic and imaging features of FLNA-negative patients with bilateral periventricular nodular heterotopia and epilepsy.

Authors:  Zianka Fallil; Heath Pardoe; Robert Bachman; Benjamin Cunningham; Isha Parulkar; Catherine Shain; Annapurna Poduri; Robert Knowlton; Ruben Kuzniecky
Journal:  Epilepsy Behav       Date:  2015-09-02       Impact factor: 2.937

Review 3.  Seizure-induced oxidative stress in temporal lobe epilepsy.

Authors:  Sreekanth Puttachary; Shaunik Sharma; Sara Stark; Thimmasettappa Thippeswamy
Journal:  Biomed Res Int       Date:  2015-01-20       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.